why is tirzepatide being taken off the market Trends, Share and Forecast, 2026-2033 Tirzepatide is NO longer in

(PubMed) Schoenen J, Jacquy J, Lenaerts M

T.CummingsC.GargusJ

A slight, non-significant trend to a higher improvement in the CKD cohort ( Supplementary Table 4 ), which was irrespective of CKD severity (not shown), could be observed

To avoid missing a correlation due to different cutoff values (e.g., because of using a median gene expression as a cutoff), each analysis was performed by using the best available cutoff

The increased effectiveness is likely because tirzepatide products like Mounjaro target two metabolic hormone receptors GIPs and GLP-1s compared to semaglutide products like Ozempic and Wegovy, which only target GLP-1s

S., & Odde, D